Literature DB >> 10384971

Effect of a urinary control insert on quality of life in incontinent women.

P K Sand1, D Staskin, J Miller, A Diokno, G R Sant, G W Davila, P Knapp, S Rappaport, R Tutrone.   

Abstract

The aim of the study was to evaluate the efficacy, safety and effect on quality of life of the Reliance urinary control insert (Uromed Corp., Needham, MA) in women with genuine stress incontinence. Efficacy was evaluated at baseline and at the end of the 12-month study period by standardized pad-weight studies and by rating scales measuring acceptability, incontinence symptom improvement, ease of learning, comfort and time to habituation, recorded in diaries at monthly intervals in 63 women. The SF-36 Health Survey questionnaire was used to assess quality of life status at baseline without the device and after 12 months of device use. A significant decrease in urine loss at 12 months compared with baseline was shown by standardized pad-weight studies, with and without the device in situ. Urine loss was reduced by more than 80% in 91% of the 63 patients, and 79% were completely dry. Patient diaries showed significant improvement in control of leakage, comfort, and ease of device use during the study period. Short-term-36 Health Status data also indicated significant improvement in the physical functioning score at 12 months. Urinary tract infection and hematuria were the most common adverse effects. The Reliance urinary control insert is an efficacious and safe means of controlling genuine stress incontinence in women. The device was perceived as easy to use and comfortable for these 63 women, and resulted in improved quality of life.

Entities:  

Mesh:

Year:  1999        PMID: 10384971     DOI: 10.1007/pl00004016

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  3 in total

Review 1.  Incontinence-specific quality of life measures used in trials of treatments for female urinary incontinence: a systematic review.

Authors:  Sue Ross; Dana Soroka; Amalia Karahalios; Cathryn M A Glazener; E Jean C Hay-Smith; Harold P Drutz
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2005-07-16

2.  A randomized controlled trial of the NEAT expandable tip continence device.

Authors:  H Robinson; J Schulz; C Flood; L Hansen
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2003-07-09

Review 3.  An assessment of validity and responsiveness of generic measures of health-related quality of life in hearing impairment.

Authors:  Yaling Yang; Louise Longworth; John Brazier
Journal:  Qual Life Res       Date:  2013-05-26       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.